Drugs / Monovalent GBS-CRM glycoconjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00657683 | Dec 2007 → Apr 2009 | group B streptococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent GBS-CRM glycoconjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00657683 ↗ |
| Modality | Vaccine | “a GBS vaccine” NCT00657683 ↗ |